Search results
Author(s):
Inga Narbute
,
Sanda Jegere
,
Indulis Kumsars
,
et al
Added:
3 years ago
Coronary bifurcation disease is present in up to 15–20 % of lesions undergoing percutaneous coronary intervention (PCI) and remains one of the outstanding challenges of treatment with PCI.1,2 PCI for coronary bifurcations is associated with more procedural complications and higher restenosis and adverse event rates than lesions in the body of the vessel.3–7 The introduction of drug-eluting stents…
View more
Author(s):
Inga Narbute
,
Sanda Jegere
,
Indulis Kumsars
,
et al
Added:
3 years ago
Abstract
Together with calcified lesions, saphenous vein grafts, chronic total occlusions and unprotected left main lesions, bifurcation lesions are complex lesions that remain among the outstanding challenges of treatment with percutaneous coronary intervention. Bifurcation lesions are associated with increased rates of procedural complications, restenosis and adverse events than lesions in the…
View more
Author(s):
Goran Stankovic
,
Zlatko Mehmedbegovic
,
Milorad Zivkovic
Added:
3 years ago
Approximately 15–20% of percutaneous coronary interventions (PCIs) are performed to treat coronary bifurcations. These procedures are renowned for being technically challenging and historically have been associated with lower procedural success rates and worse clinical outcomes compared with non-bifurcation lesions.1,2
A bifurcation lesion is a lesion occurring at, or adjacent to, a significant…
View more
ABSORB BVS Implantation in Bifurcation Lesions - Current Evidence and Practical Recommendations
Author(s):
Robin P Kraak
,
Maik J Grundeken
,
Robbert J de Winter
,
et al
Added:
3 years ago
Article
Author(s):
Maciej Lesiak
Added:
3 years ago
While provisional stenting has remained the preferred strategy for majority of bifurcation lesions, controversies still exist regarding when and how to use complex techniques. Most of randomised studies comparing simple and complex approaches have focused on selected populations, included both ‘true’ and ‘non-true’ bifurcation lesions, used first-generation drug eluting stents (DES) and favoured…
View more
Author(s):
Angela Hoye
,
Scot Garg
Added:
3 years ago
Coronary artery bifurcations are at an increased risk of the development of coronary atherosclerosis because of turbulent flow and low shear stress. Bifurcation lesions account for between 8% and 22% of all percutaneous coronary interventions (PCI) and have long posed a problem for interventional cardiologists.
Published data show bifurcation lesions treated using bare metal stents (BMS) have…
View more
Author(s):
,
Adriano Caixeta
,
Gregg Stone
Added:
3 years ago
Accurate characterisation of coronary artery disease (CAD) anatomy based on the diagnostic angiogram is essential to select the optimal strategy of revascularisation. Recently, the SYNTAX score generated a great amount of interest because of its ability to risk-stratify and discriminate outcomes of patients with complex CAD undergoing percutaneous coronary intervention (PCI) as compared to…
View more
Author(s):
Shao-Liang Chen
,
Imad Sheiban
Added:
3 years ago
Bifurcation lesions account for approximately 20–30% of all percutaneous coronary interventions (PCIs). Coronary bifurcation sites are prone to developing obstructive atherosclerotic disease due to turbulent blood flow and change of shear stress. With the complexity of bifurcation lesions, several classification systems have been advocated in order to extablish percutaneous strategies.1–3 In fact…
View more
Author(s):
Joelle Kefer
Added:
3 years ago
Atrial septal abnormalities are common congenital lesions remaining asymptomatic until adulthood in a great number of patients. The most frequent atrial septal defects in adults are ostium secundum atrial septal defect (ASD) and patent foramen ovale (PFO), both approachable by transcatheter closure using device implantation. The first non-surgical ASD closure was performed in 1975 by Mills and…
View more
Author(s):
Albert Schömig
,
Adnan Kastrati
Added:
3 years ago
Drug-eluting stents (DES) have largely resolved the problem of restenosis, which is the major limitation of plain balloon angioplasty and bare-metal stenting.1 While several DES platforms have been evaluated in the setting of randomised studies and used in clinical practice, most of the accumulated evidence is related to sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES).2 These…
View more